LSD study shows that the 100 mg dose in most patients decreases anxiety considerably
A groundbreaking new study has revealed that Lyergic Zuuriethylamide (LSD), commonly known as acid, may hold the key to reducing anxiety in individuals. This study, conducted by Daniel Karlin, MD, Chief Medical Officer of MindMed in New York, marks the first of its kind to evaluate the safety and efficacy of MM120, a pharmaceutical formulation of LSD, as a monotherapy for patients with moderate to severe generalized anxiety disorder.
Published in the Journal of the American Medical Association, the study involved nearly 200 adults between the ages of 18 and 74 who were given either MM120 or a placebo for a three-month period. Dosing sessions were conducted in private rooms with trained monitors present, and no psychotherapy was provided during the sessions.
Researchers monitored changes in anxiety scores at various intervals throughout the study, with the most significant improvements seen in patients who received the highest doses of LSD. After 12 weeks, 65% of patients using 100 micrograms of LSD showed benefits, with nearly half experiencing a remission of their anxiety symptoms.
In addition to reducing anxiety, LSD was also found to have a positive impact on depression, with higher doses leading to significant improvements. However, side effects such as hallucinations, nausea, and headaches were reported by participants.
The study revealed that the effects of LSD were dose-dependent, with 100 micrograms being the optimal dose for reducing anxiety. Plans are now in place for two large late-phase studies to further evaluate the long-term effects of LSD on mental health.
Despite the promising results of the study, LSD remains classified as a Schedule I drug, meaning it is deemed to have a high potential for abuse and no accepted medical use. However, the FDA has designated LSD, along with Psilocybin and MDMA, as “potential breakthrough therapies” for mental health conditions.
While the study shows promise for the use of LSD in treating anxiety and depression, experts caution that careful supervision and further research are necessary to fully understand the potential risks and benefits of psychedelic therapy. Miley Cyrus reveals the ‘powerful’ therapy that helped her to conquer theater shell
It is important to note that LSD can cause hallucinations and other side effects such as paranoia, mood swings, and increased heart rate. However, advocates for psychedelic therapy believe that the potential benefits outweigh the risks, especially when administered in a clinical setting.
Health and human service secretary Robert F. Kennedy Jr. and Ministry of Veteran Affairs Doug Collins have expressed interest in exploring psychedelic therapy further. While the road to approval for LSD as a medical treatment may be long, researchers and advocates remain hopeful that psychedelic therapy could offer a new approach to mental health care.
For more health articles and updates, visit www.foxnews.com/Health.
This article was rewritten by Ashley J. Dimella, a lifestyle reporter with Fox News Digital.
